HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

MDLN

Medline Inc. (NASDAQ)

Healthcare — Medical Instruments & Supplies

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Buy 1.5 / 5 27 analysts
$37.46
$-1.63 (-4.17%)
Target: $51.15 (36.5%)
Sign in to add MDLN to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$74.35B
P/E Ratio (TTM)36.61
Forward P/E25.02
EPS (TTM)$1.14
Dividend Yield-
Profit Margin3.32%
Revenue Growth10.70%
ROE6.05%
Debt/Equity65.31
Recommendation Buy 1.5
Analyst Target$51.15
Analysts27
Indexes NASDAQ

Technical Indicators

RSI (14)72.0
Beta-
SMA 20-
SMA 40-
52-Week High$50.88
52-Week Low$32.82
50-Day Avg$38.87
200-Day Avg$42.21
Avg Volume$9.76M
Volume$2.85M

Performance Analysis

NEUTRAL

MDLN presents a mixed picture with both positive and negative indicators.

~ Trading at 26% of its 52-week range.
- RSI at 72.0 indicates overbought conditions — a pullback may be due.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 10.7% year-over-year.
+ Wall Street consensus is "Buy" from 27 analysts.
+ Average analyst target of $51.15 implies 36.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:19 UTC

Back to Screener Export Report